• 1
    O’Callaghan A & Mead GM Progress in the management of solid tumours. Testicular carcinoma. Postgrad Med J 1997; 73: 481 6
  • 2
    Segelov E, Cox KM, McNeil RE, Lancaster L, Rogers J The impact of histological review on clinical management of testicular cancer. Br J Urol 1993; 71: 736 8
  • 3
    Ellman R & Anderson TJUK National Coordinating Group for Breast Screening Pathology; Sloan JP, et al. Consistency of histopathological reporting of breast lesions detected by screening: findings of the UK National External Quality Assessment (EQA) Scheme. Eur J Cancer 1994; 30A: 1414 9
  • 4
    Keehn R, Auerbach O, Nambu S et al. Reproducibility of major diagnoses in a binational study of lung cancer of uranium miners and atomic bomb survivors. Am J Clin Pathol 1994; 101: 478 82
  • 5
    Damjanov ITumors of the testis and epididymis. In Murphy WM, ed, Urological Pathology Chapt 6 Philadelphia: Saunders, 1989; 314 79
  • 6
    Sesterhenn IA, Weiss RB, Mostofi K et al. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study. J Clin Oncol 1992; 10: 69 78
  • 7
    Pinder SE, Ellis IO, Galea M, O’Rouke S, Blamey RW, Elston CW Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994; 24: 41 7
  • 8
    Maher TM & Lee AHS Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis. Histopathology 1998; 32: 217 24
  • 9
    Department of Health Policy Framework for Commissioning Cancer Services; Guidance for Purchasers and Providers of Cancer Services. London: HMSO, 1995